Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
LifeMD, Inc. stock logo
LFMD
LifeMD
$11.65
+7.7%
$9.32
$1.40
$12.01
$470.31M1.43809,978 shs352,980 shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
LifeMD, Inc. stock logo
LFMD
LifeMD
-3.05%+5.97%-2.17%+84.33%+595.82%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
LifeMD, Inc. stock logo
LFMD
LifeMD
0.5133 of 5 stars
1.54.00.00.02.60.80.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
LifeMD, Inc. stock logo
LFMD
LifeMD
3.00
Buy$10.40-10.73% Downside

Current Analyst Ratings

Latest LFMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/23/2024
LifeMD, Inc. stock logo
LFMD
LifeMD
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$13.00 ➝ $14.00
3/15/2024
LifeMD, Inc. stock logo
LFMD
LifeMD
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$11.00 ➝ $13.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
LifeMD, Inc. stock logo
LFMD
LifeMD
$152.55M3.08N/AN/A$0.15 per share77.67

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
LifeMD, Inc. stock logo
LFMD
LifeMD
-$20.60M-$0.70N/AN/AN/A-14.01%N/A-50.74%5/8/2024 (Confirmed)

Latest LFMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.13N/A+$0.13N/AN/AN/A  
3/11/2024Q4 2023
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.14-$0.12+$0.02-$0.12$40.65 million$44.86 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
LifeMD, Inc. stock logo
LFMD
LifeMD
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
LifeMD, Inc. stock logo
LFMD
LifeMD
3.22
1.22
1.15

Ownership

Institutional Ownership

CompanyInstitutional Ownership
LifeMD, Inc. stock logo
LFMD
LifeMD
35.52%

Insider Ownership

CompanyInsider Ownership
LifeMD, Inc. stock logo
LFMD
LifeMD
18.89%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
LifeMD, Inc. stock logo
LFMD
LifeMD
20740.37 million32.74 millionOptionable

LFMD Headlines

SourceHeadline
LifeMD to Report First Quarter 2024 Financial Results on May 8LifeMD to Report First Quarter 2024 Financial Results on May 8
globenewswire.com - April 24 at 8:00 AM
LifeMD (NASDAQ:LFMD) Price Target Increased to $14.00 by Analysts at BTIG ResearchLifeMD (NASDAQ:LFMD) Price Target Increased to $14.00 by Analysts at BTIG Research
americanbankingnews.com - April 24 at 4:44 AM
LifeMD to Participate in Upcoming Investor and Industry Conferences During MayLifeMD to Participate in Upcoming Investor and Industry Conferences During May
finance.yahoo.com - April 23 at 8:37 AM
LifeMD (NASDAQ:LFMD) Given New $14.00 Price Target at BTIG ResearchLifeMD (NASDAQ:LFMD) Given New $14.00 Price Target at BTIG Research
marketbeat.com - April 23 at 8:20 AM
LifeMD, Inc. (NASDAQ:LFMD) Sees Significant Growth in Short InterestLifeMD, Inc. (NASDAQ:LFMD) Sees Significant Growth in Short Interest
marketbeat.com - April 13 at 1:53 PM
Buy Rating Affirmed for LifeMD Amid Favorable Legal Outlook and Competitive StrengthsBuy Rating Affirmed for LifeMD Amid Favorable Legal Outlook and Competitive Strengths
markets.businessinsider.com - April 12 at 2:34 PM
Alkermes Sleeping Disorder Studies Data Look Excellent, Analyst SaysAlkermes' Sleeping Disorder Studies' Data Look Excellent, Analyst Says
markets.businessinsider.com - April 9 at 2:56 PM
LifeMD, Inc. (NASDAQ:LFMD) Short Interest UpdateLifeMD, Inc. (NASDAQ:LFMD) Short Interest Update
marketbeat.com - March 29 at 8:18 PM
LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceLifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference
globenewswire.com - March 25 at 8:00 AM
LifeMD Shares Come Back to Life on GLP-1 Business GrowthLifeMD Shares Come Back to Life on GLP-1 Business Growth
marketbeat.com - March 19 at 6:05 AM
LifeMD Shares Come Back to Life on GLP-1 Business Growth LifeMD Shares Come Back to Life on GLP-1 Business Growth
marketbeat.com - March 19 at 6:05 AM
LifeMD Full Year 2023 Earnings: Beats ExpectationsLifeMD Full Year 2023 Earnings: Beats Expectations
finance.yahoo.com - March 13 at 6:20 PM
Can WeightWatchers Regain its Mojo after Oprah Steps Down?  (LFMD)Can WeightWatchers Regain its Mojo after Oprah Steps Down? (LFMD)
marketbeat.com - March 13 at 2:18 PM
Can WeightWatchers Regain Its Mojo after Oprah Steps Down?Can WeightWatchers Regain Its Mojo after Oprah Steps Down?
marketbeat.com - March 13 at 7:04 AM
LifeMD Poised for Growth: Strong Q4 Performance and Positive FY24 Outlook Reinforce Buy RatingLifeMD Poised for Growth: Strong Q4 Performance and Positive FY24 Outlook Reinforce Buy Rating
markets.businessinsider.com - March 12 at 3:28 PM
LifeMD Shares Jump on Strong 4QLifeMD Shares Jump on Strong 4Q
marketwatch.com - March 11 at 6:46 PM
LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue EstimatesLifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates
zacks.com - March 11 at 6:31 PM
LifeMD Reports Fourth Quarter 2023 ResultsLifeMD Reports Fourth Quarter 2023 Results
globenewswire.com - March 11 at 4:05 PM
Heres what to expect from LifeMDs earningsHere's what to expect from LifeMD's earnings
markets.businessinsider.com - March 10 at 12:06 PM
Get Your Shopping List Ready: Heres How to Buy PullbacksGet Your Shopping List Ready: Here's How to Buy Pullbacks
realmoney.thestreet.com - March 5 at 12:26 PM
Hims & Hers Stock Rises On Stimulating Earnings Growth (LFMD)Hims & Hers Stock Rises On Stimulating Earnings Growth (LFMD)
marketbeat.com - March 5 at 6:05 AM
LifeMD Insiders Placed Bullish Bets Worth US$1.24mLifeMD Insiders Placed Bullish Bets Worth US$1.24m
finance.yahoo.com - February 27 at 10:21 AM
LifeMD to Report Fourth Quarter 2023 Financial Results on March 11LifeMD to Report Fourth Quarter 2023 Financial Results on March 11
finance.yahoo.com - February 26 at 8:54 AM
Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Tandem Diabetes Care (TNDM)Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Tandem Diabetes Care (TNDM)
markets.businessinsider.com - February 17 at 12:18 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

LifeMD logo

LifeMD

NASDAQ:LFMD
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.